{"nctId":"NCT01792830","briefTitle":"Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients","startDateStruct":{"date":"2012-10"},"conditions":["Poor Glycemic Control"],"count":175,"armGroups":[{"label":"Control HbA1c < 7%","type":"NO_INTERVENTION","interventionNames":[]},{"label":"Diabetic/ Metformin and 50-Glargine HbA1c 7%- 9%","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Metformin","Drug: Glargine insulin"]},{"label":"Diabetic/ Metformin and 80-Glargine HbA1c 7%-9%%","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Metformin","Drug: Glargine insulin"]},{"label":"No diabetes/ Metformin only","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Metformin"]},{"label":"Diabetic/antidiabetic regimen","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Metformin","Drug: Glargine insulin"]},{"label":"No diabetes/ Insulin only","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Glargine insulin"]},{"label":"Diabetes/Insulin only","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Glargine insulin","Drug: Glulisine"]}],"interventions":[{"name":"Metformin","otherNames":["Glucophage"]},{"name":"Glargine insulin","otherNames":["Lantus"]},{"name":"Glulisine","otherNames":["Apidra"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Males or females between the ages of 18 and 80 years undergoing primary coronary artery bypass graft surgery (CABG).\n2. Post surgical hyperglycemia (Blood glucose \\>140 mg/dl)\n3. Patients with and without a history of type 2 diabetes\n\nExclusion Criteria:\n\n1. Patients with severely impaired renal function (serum creatinine ≥3.0 mg/dl or a glomerular filtration rate \\< 30 ml/min) or clinically significant hepatic failure.\n2. Subjects with acute hyperglycemic crises such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic states.\n3. Moribund patients and those at imminent risk of death (brain death or cardiac standstill).\n4. Patients or next-to-kin with mental conditions rendering the subject or family member unable to understand the nature, scope, and possible consequences of the study.\n5. Female subjects who are pregnant or breast-feeding at time of enrollment into the study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Efficacy, Measured by a Change in HbA1c Levels","description":"Change in the level of HbA1c in a one month period after discharge from the hospital. The A1c test result is reported as a percentage. Higher percentages indicate higher blood glucose levels in the previous three months. A normal HbA1c level is below 5.7 percent.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.09","spread":"0.43"},{"groupId":"OG001","value":"5.2","spread":"0.00"},{"groupId":"OG002","value":"5.5","spread":"0.5"},{"groupId":"OG003","value":"5.8","spread":"0.5"},{"groupId":"OG004","value":"6.9","spread":"1.60"},{"groupId":"OG005","value":"6.1","spread":"2.60"},{"groupId":"OG006","value":"6.3","spread":"0.89"},{"groupId":"OG007","value":"6.6","spread":"0.70"},{"groupId":"OG008","value":"8.6","spread":"1.9"},{"groupId":"OG009","value":"6.9","spread":"0.4"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Readmitted to the Hospital","description":"The number of participants that were readmitted to the hospital 3 months after initial hospital discharge","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"1","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null},{"groupId":"OG009","value":"0","spread":null},{"groupId":"OG010","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"The Number of Participants Experiencing a Hypoglycemic Event","description":"The number of participants that experienced hypoglycemia, defined as blood glucose levels ≤70 mg/dl.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"1","spread":null},{"groupId":"OG008","value":"2","spread":null},{"groupId":"OG009","value":"0","spread":null},{"groupId":"OG010","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"The Number of Participants Experiencing a Severe Hypoglycemic Event","description":"The number of participants that experienced severe hypoglycemia, defined as blood glucose levels ≤ 40 mg/dl.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null},{"groupId":"OG008","value":"0","spread":null},{"groupId":"OG009","value":"0","spread":null},{"groupId":"OG010","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Experiencing a Hyperglycemic Event","description":"The number of participants that experienced hyperglycemia, defined as blood glucose levels ≥ 140 mg/dl.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"1","spread":null},{"groupId":"OG005","value":"1","spread":null},{"groupId":"OG006","value":"3","spread":null},{"groupId":"OG007","value":"1","spread":null},{"groupId":"OG008","value":"3","spread":null},{"groupId":"OG009","value":"3","spread":null},{"groupId":"OG010","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":84},"commonTop":["Trauma from car accident","Stomach virus","Hematoma","Bladder cancer","Anemia"]}}}